Tat'Yana Ivanovna Torkhovskaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tat'Yana Ivanovna Torkhovskaya has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
O. M. Ipatova
Institute of Biomedical Chemistry, ul. Pogodinskaya 10, 119121, Moscow, Russia
12 shared publicationsT. S. Zakharova
Institute of Biomedical Chemistry, ul. Pogodinskaya 10, 119121, Moscow, Russia
9 shared publicationsN. V. Medvedeva
Institute of Biomedical Chemistry
5 shared publicationsE. M. Khalilov
Federal Agency for Health Care and Social Development
4 shared publications- Vasily A. Kudinov
Laboratory of Cell Biology and Developmental Pathology, FSBSI Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia
4 shared publications E. G. Tikhonova
Institute of Biomedical Chemistry, ul. Pogodinskaya 10, 119121, Moscow, Russia
3 shared publications
Latest Publications
- Open Access
- 1 October 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 142, 111985
Composite phospholipid-gold nanoparticles with targeted fragment for tumor imaging
- 1 October 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 142, 111985
Open AccessComposite phospholipid-gold nanoparticles with targeted fragment for tumor imaging
- Open Access
- 1 September 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111900
High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis
- 1 September 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111900
Open AccessHigh-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis
- Open Access
- 1 February 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 134, 111154
Chlorin e6 embedded in phospholipid nanoparticles equipped with specific peptides: Interaction with tumor cells with different aminopeptidase N expression
- 1 February 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 134, 111154
Open AccessChlorin e6 embedded in phospholipid nanoparticles equipped with specific peptides: Interaction with tumor cells with different aminopeptidase N expression
- Open Access
- 19 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8737
High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
It is well known that blood lipoproteins (LPs) are multimolecular complexes of lipids and proteins that play a crucial role in lipid transport. High-density lipoproteins (HDL) are a class of blood plasma LPs that mediate reverse cholesterol transport (RCT)—cholesterol transport from the peripheral tissues to the liver. Due to this ability to promote cholesterol uptake from cell membranes, HDL possess antiatherogenic properties. This function was first observed at the end of the 1970s to the beginning of the 1980s, resulting in high interest in this class of LPs. It was shown that HDL are the prevalent class of LPs in several types of living organisms (from fishes to monkeys) with high resistance to atherosclerosis and cardiovascular disorders. Lately, understanding of the mechanisms of the antiatherogenic properties of HDL has significantly expanded. Besides the contribution to RCT, HDL have been shown to modulate inflammatory processes, blood clotting, and vasomotor responses. These particles also possess antioxidant properties and contribute to immune reactions and intercellular signaling. Herein, we review data on the structure and mechanisms of the pleiotropic biological functions of HDL from the point of view of their evolutionary role and complex dynamic nature.
- 19 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8737
Open AccessHigh-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
It is well known that blood lipoproteins (LPs) are multimolecular complexes of lipids and proteins that play a crucial role in lipid transport. High-density lipoproteins (HDL) are a class of blood plasma LPs that mediate reverse cholesterol transport (RCT)—cholesterol transport from the peripheral tissues to the liver. Due to this ability to promote cholesterol uptake from cell membranes, HDL possess antiatherogenic properties. This function was first observed at the end of the 1970s to the beginning of the 1980s, resulting in high interest in this class of LPs. It was shown that HDL are the prevalent class of LPs in several types of living organisms (from fishes to monkeys) with high resistance to atherosclerosis and cardiovascular disorders. Lately, understanding of the mechanisms of the antiatherogenic properties of HDL has significantly expanded. Besides the contribution to RCT, HDL have been shown to modulate inflammatory processes, blood clotting, and vasomotor responses. These particles also possess antioxidant properties and contribute to immune reactions and intercellular signaling. Herein, we review data on the structure and mechanisms of the pleiotropic biological functions of HDL from the point of view of their evolutionary role and complex dynamic nature.
- 1 January 2020
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 14 (1) , 78-81
Prednisolone in Phospholipid Nanoparticles: Prolonged Circulation and Increased Antiinflammatory Effect
Besides application of newly developed pharmacological agents many therapeutic schemes employ known effective drugs, particularly glucocorticoids. Prednisolone, one of the most commonly used glucocorticoids, is characterized by pronounced anti-inflammatory activity. Its major disadvantage consists in short-term circulation in the blood and the need of repeated injections, which can cause side effects. In this regard, many attempts are undertaken to develop more effective and safer dosage forms of this drug substance. We have obtained a prednisolone composition incorporated into nanoparticles of soybean phosphatidylcholine with an average diameter of 20 nm. The oral administration of this composition in rats increased maximal prednisolone concentrations in plasma and duration of its circulation as compared with administration of the free drug substance. In mice with a model of inflammation induced by subplantar injection of conconavalin A, the index of the inflammation reaction (determined by paw edema) decreased in the case of the prednisolone composition in nanoparticles significantly more actively than after administration of the free drug substance: the maximum index decrease (62.2% compared to 49.6%) was observed already at the minimum dose of prednisolone administered (2.5 mg/kg), free drug substance at this dose was ineffective. The results indicate an increase in the effectiveness of prednisolone incorporated into phospholipid nanoparticles; this makes it possible to reduce the administered dose and the risk of side effects as well.
- 1 January 2020
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 14 (1) , 78-81
Prednisolone in Phospholipid Nanoparticles: Prolonged Circulation and Increased Antiinflammatory Effect
Besides application of newly developed pharmacological agents many therapeutic schemes employ known effective drugs, particularly glucocorticoids. Prednisolone, one of the most commonly used glucocorticoids, is characterized by pronounced anti-inflammatory activity. Its major disadvantage consists in short-term circulation in the blood and the need of repeated injections, which can cause side effects. In this regard, many attempts are undertaken to develop more effective and safer dosage forms of this drug substance. We have obtained a prednisolone composition incorporated into nanoparticles of soybean phosphatidylcholine with an average diameter of 20 nm. The oral administration of this composition in rats increased maximal prednisolone concentrations in plasma and duration of its circulation as compared with administration of the free drug substance. In mice with a model of inflammation induced by subplantar injection of conconavalin A, the index of the inflammation reaction (determined by paw edema) decreased in the case of the prednisolone composition in nanoparticles significantly more actively than after administration of the free drug substance: the maximum index decrease (62.2% compared to 49.6%) was observed already at the minimum dose of prednisolone administered (2.5 mg/kg), free drug substance at this dose was ineffective. The results indicate an increase in the effectiveness of prednisolone incorporated into phospholipid nanoparticles; this makes it possible to reduce the administered dose and the risk of side effects as well.
- 1 September 2019
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 45 (5) , 335-346
Human Blood Plasma Lipidome: Opportunities and Prospects of Its Analysis in Medical Chemistry
The emerging development of new analytical mass spectrometry technologies resulted in the possibility of a detailed fractionation of biologically important compounds. As applied to lipids, it...
- 1 September 2019
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 45 (5) , 335-346
Human Blood Plasma Lipidome: Opportunities and Prospects of Its Analysis in Medical Chemistry
The emerging development of new analytical mass spectrometry technologies resulted in the possibility of a detailed fractionation of biologically important compounds. As applied to lipids, it...
- 26 July 2019
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 167 (3) , 347-350
Effect of Cell-Penetrating Arginine Peptide on Interaction of Photosensitizer Chlorin e6 Incorporated into Phospholipid Nanoparticles with Tumor Cells
We studied the possibility of increasing the efficiency of photodynamic therapy by improving delivery of photosensitizers chlorin e6 into tumor cells. Previous studies showed that incorporation of chlorin e6 onto phospholipid nanoparticles with a diameter <20 nm reduces its cytotoxicity due to accelerated elimination from organs [8]. A heptapeptide R7 synthesized and added to this combination promoted internalization of chlorin e6 into HepG2 cells in comparison with initial nanoparticles without peptide R7. The observed effect of peptide R7 can be explained by activation of endocytosis and/or macropinocytosis (bearing in mind the interaction of arginine with carboxyl groups of e6. The development of this transporting system is a promising trend in photodynamic therapy of cancer diseases.
- 26 July 2019
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 167 (3) , 347-350
Effect of Cell-Penetrating Arginine Peptide on Interaction of Photosensitizer Chlorin e6 Incorporated into Phospholipid Nanoparticles with Tumor Cells
We studied the possibility of increasing the efficiency of photodynamic therapy by improving delivery of photosensitizers chlorin e6 into tumor cells. Previous studies showed that incorporation of chlorin e6 onto phospholipid nanoparticles with a diameter <20 nm reduces its cytotoxicity due to accelerated elimination from organs [8]. A heptapeptide R7 synthesized and added to this combination promoted internalization of chlorin e6 into HepG2 cells in comparison with initial nanoparticles without peptide R7. The observed effect of peptide R7 can be explained by activation of endocytosis and/or macropinocytosis (bearing in mind the interaction of arginine with carboxyl groups of e6. The development of this transporting system is a promising trend in photodynamic therapy of cancer diseases.
- 1 November 2018
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 44 (6) , 608-618
High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport
Among blood plasma lipoproteins that transport lipids in the organism, a significant role belongs to high-density lipoproteins (HDL). They protect against atherosclerosis progression, mainly through...
- 1 November 2018
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 44 (6) , 608-618
High Density Lipoproteins Phosphatidylcholine as a Regulator of Reverse Cholesterol Transport
Among blood plasma lipoproteins that transport lipids in the organism, a significant role belongs to high-density lipoproteins (HDL). They protect against atherosclerosis progression, mainly through...
- Open Access
- 9 December 2015
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 70 (6) , 727-733
Neuropeptides, Cytokines and Thymus Peptides as Effectors of Interactions Between Thymus and Neuroendocrine System
В обзоре приведены данные о взаимодействии нейроэндокринной системы и тимуса, осуществляемом через нейроэндокринно-иммунные адаптивные системы организма. Присутствие адренергических и пептидергических нервов в тимусе создает условия для воздействия продуцируемых ими нейропептидов. Последние активируют рецепторы на тимических клетках, влияя на основные процессы в тимусе, включая созревание Т лимфоцитов, продукцию цитокинов, гормонов и пептидов. В свою очередь, продуцируемые тимусом пептиды и/или контролируемые ими цитокины проникают в мозг, влияя на функции нейронов, что создает основу для поведенческих изменений и поддержания гомеостаза в ответ на инфекцию. При старении организма, а также ряде заболеваний — инфекционных, аутоиммунных, нейродегенеративных, онкологических — показаны нарушения взаимодействий процессов в тимусе и центральной нервной системе. Механизмы сигнальных реакций, определяющих эти взаимодействия, еще не ясны, и их понимание будет способствовать развитию комплексных эффективных терапевтических стратегий.
- 9 December 2015
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 70 (6) , 727-733
Open AccessNeuropeptides, Cytokines and Thymus Peptides as Effectors of Interactions Between Thymus and Neuroendocrine System
В обзоре приведены данные о взаимодействии нейроэндокринной системы и тимуса, осуществляемом через нейроэндокринно-иммунные адаптивные системы организма. Присутствие адренергических и пептидергических нервов в тимусе создает условия для воздействия продуцируемых ими нейропептидов. Последние активируют рецепторы на тимических клетках, влияя на основные процессы в тимусе, включая созревание Т лимфоцитов, продукцию цитокинов, гормонов и пептидов. В свою очередь, продуцируемые тимусом пептиды и/или контролируемые ими цитокины проникают в мозг, влияя на функции нейронов, что создает основу для поведенческих изменений и поддержания гомеостаза в ответ на инфекцию. При старении организма, а также ряде заболеваний — инфекционных, аутоиммунных, нейродегенеративных, онкологических — показаны нарушения взаимодействий процессов в тимусе и центральной нервной системе. Механизмы сигнальных реакций, определяющих эти взаимодействия, еще не ясны, и их понимание будет способствовать развитию комплексных эффективных терапевтических стратегий.